Aug 15 |
AbbVie Announces Ontario and Quebec are First Provinces to Reimburse Subcutaneous EPKINLYâ„¢ (epcoritamab) for the Treatment of Diffuse Large B-Cell Lymphoma Under New Early Access Process
|
Aug 15 |
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
|
Aug 15 |
Medicare to save $6B in 2026 from the first ever Part D drug pricing negotiations
|
Aug 15 |
The 3 Best Stocks to Buy to Survive Another S&P 500 Crash
|
Aug 14 |
Syros (SYRS) Falls 62% on Phase II Leukemia Study Termination
|
Aug 14 |
The Zacks Analyst Blog Highlights Alphabet, AbbVie, Qualcomm and Flanigan's
|
Aug 14 |
The Zacks Analyst Blog Highlights Eli Lilly, Pfizer, AbbVie and Biogen
|
Aug 14 |
We Think You Can Look Beyond AbbVie's (NYSE:ABBV) Lackluster Earnings
|
Aug 13 |
Analyst revises AbbVie stock price target on drug-sale estimates
|
Aug 13 |
Top Research Reports for Alphabet, AbbVie & QUALCOMM
|